TY - JOUR AU - Feldman, B. M. AU - Rider, L. G. AU - Reed, A. M. AU - Pachman, L. M. PY - 2008 DA - 2008// TI - Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood JO - Lancet VL - 371 UR - https://doi.org/10.1016/S0140-6736(08)60955-1 DO - 10.1016/S0140-6736(08)60955-1 ID - Feldman2008 ER - TY - JOUR AU - Lundberg, I. E. AU - Tjamlund, A. AU - Bottai, M. AU - Pikington, C. AU - Visser, M. AU - Alfredson, L. PY - 2017 DA - 2017// TI - 2017 European league against rheumatism/ American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups JO - Arthritis Rheum VL - 69 UR - https://doi.org/10.1002/art.40320 DO - 10.1002/art.40320 ID - Lundberg2017 ER - TY - STD TI - Gordon PA, Winer JB, Hoogendijk JE, Choy EH. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis. Cochrane Database Syst Rev. 2012:CD003643. ID - ref3 ER - TY - JOUR AU - Leclair, V. AU - Lundberg, I. E. PY - 2017 DA - 2017// TI - Recent clinical trials in idiopathic inflammatory myopathies JO - Curr Opin Rheumatol VL - 29 ID - Leclair2017 ER - TY - JOUR AU - Iberati, A. AU - Altman, D. G. AU - Tetzlaff, J. AU - Mulrow, C. AU - Gøtzsche, P. C. AU - Ioannidis, J. P. PY - 2009 DA - 2009// TI - The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration JO - BMJ VL - 339 UR - https://doi.org/10.1136/bmj.b2700 DO - 10.1136/bmj.b2700 ID - Iberati2009 ER - TY - STD TI - Oxford centre for evidence-based medicine - Levels of evidence (March 2009) - CEBM. 2009. ID - ref6 ER - TY - JOUR AU - Guyatt, G. H. AU - Oxman, A. D. AU - Kunz, R. AU - Falck-Ytter, Y. AU - Vist, G. E. AU - Liberati, A. PY - 2008 DA - 2008// TI - Going from evidence to recommendations JO - BMJ VL - 336 UR - https://doi.org/10.1136/bmj.39493.646875.AE DO - 10.1136/bmj.39493.646875.AE ID - Guyatt2008 ER - TY - JOUR AU - Guyatt, G. H. AU - Oxman, A. D. AU - Vist, G. E. AU - Kunz, R. AU - Falck-Ytter, Y. AU - Alonso-Coello, P. PY - 2008 DA - 2008// TI - GRADE: an emerging consensus on rating quality of evidence and strength of recommendations JO - BMJ VL - 336 UR - https://doi.org/10.1136/bmj.39489.470347.AD DO - 10.1136/bmj.39489.470347.AD ID - Guyatt2008 ER - TY - JOUR AU - Kuhn, M. A. AU - Belafsky, P. C. PY - 2013 DA - 2013// TI - Management of cricopharyngeus muscle dysfunction JO - Otolaryngol Clin N Am VL - 46 UR - https://doi.org/10.1016/j.otc.2013.08.006 DO - 10.1016/j.otc.2013.08.006 ID - Kuhn2013 ER - TY - JOUR AU - Oh, T. H. AU - Brumfield, K. A. AU - Hoskin, T. L. AU - Stolp, K. A. AU - Murray, J. A. AU - Brassford, J. R. PY - 2007 DA - 2007// TI - Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62 patients JO - Mayo Clin Proc VL - 82 UR - https://doi.org/10.4065/82.4.441 DO - 10.4065/82.4.441 ID - Oh2007 ER - TY - JOUR AU - Schrey, A. AU - Airas, L. AU - Jokela, M. AU - Pulkkinen, J. PY - 2017 DA - 2017// TI - Botulinum toxin alleviates dysphagia of patients with inclusion body myositis JO - J Neurol Sci VL - 380 UR - https://doi.org/10.1016/j.jns.2017.07.031 DO - 10.1016/j.jns.2017.07.031 ID - Schrey2017 ER - TY - JOUR AU - Moerman, M. AU - Callier, Y. AU - Dick, C. AU - Vermeersch, H. PY - 2002 DA - 2002// TI - Botulinum toxin for dysphagia due to cricopharyngeal dysfunction JO - Eur Arch Otorhinolaryngol VL - 259 UR - https://doi.org/10.1007/PL00007520 DO - 10.1007/PL00007520 ID - Moerman2002 ER - TY - STD TI - Sanei-Moghaddam A, Kumar S, Jani P, Brierley C. Cricopharyngeal myotomy for cricopharyngeus stricture in an inclusion body myositis patient with hiatus hernia: a learning experience. BMJ Case Rep. 2013;2013. ID - ref13 ER - TY - JOUR AU - Marie, I. AU - Mcnard, J. F. AU - Hachulla, E. AU - Chérin, P. AU - Benveniste, O. AU - Tiev, K. PY - 2011 DA - 2011// TI - Infectious complications in polymyositis and dermatomyositis: a series of 279 patients JO - Semin Arthritis Rheum VL - 41 UR - https://doi.org/10.1016/j.semarthrit.2010.08.003 DO - 10.1016/j.semarthrit.2010.08.003 ID - Marie2011 ER - TY - JOUR AU - Gerhart, J. L. AU - Kalaaji, A. N. PY - 2010 DA - 2010// TI - Development of Pneumocystis carinii pneumonia in patients with immunobullous and connective tissue disease receiving immunosuppressive medications JO - J Am Acad Dermatol VL - 62 UR - https://doi.org/10.1016/j.jaad.2009.07.042 DO - 10.1016/j.jaad.2009.07.042 ID - Gerhart2010 ER - TY - JOUR AU - Li, J. AU - Huang, X. M. AU - Fang, W. G. AU - Zeng, X. J. PY - 2006 DA - 2006// TI - Pneumocystis carinii pneumonia in patients with connective tissue disease JO - J Clin Rheumatol VL - 12 UR - https://doi.org/10.1097/01.rhu.0000221794.24431.36 DO - 10.1097/01.rhu.0000221794.24431.36 ID - Li2006 ER - TY - JOUR AU - Ward, M. M. AU - Donald, F. PY - 1999 DA - 1999// TI - Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality JO - Arthritis Rheum VL - 42 UR - https://doi.org/3.0.CO;2-M DO - 3.0.CO;2-M ID - Ward1999 ER - TY - JOUR AU - Bachelez, H. AU - Schremmer, B. AU - Cadranel, J. AU - Mouly, F. AU - Sarfati, C. AU - Agbalika, F. PY - 1997 DA - 1997// TI - Fulminant Pneumocystis carinii pneumonia in 4 patients with dermatomyositis JO - Arch Intern Med VL - 157 UR - https://doi.org/10.1001/archinte.1997.00440340145015 DO - 10.1001/archinte.1997.00440340145015 ID - Bachelez1997 ER - TY - JOUR AU - Yale, S. H. AU - Limper, A. H. PY - 1996 DA - 1996// TI - Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy JO - Mayo Clin Proc VL - 71 UR - https://doi.org/10.4065/71.1.5 DO - 10.4065/71.1.5 ID - Yale1996 ER - TY - JOUR AU - Kadoya, A. AU - Okada, J. AU - Iikuni, Y. AU - Kondo, H. PY - 1996 DA - 1996// TI - Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis/dermatomyositis or systemic lupus erythematosus JO - J Rheumatol VL - 23 ID - Kadoya1996 ER - TY - JOUR AU - Wolfe, R. M. AU - Peacock, J. E. PY - 2017 DA - 2017// TI - Pneumocystis pneumonia (PCP) and the rheumatologist: which patients are at risk and how can PCP be prevented? JO - Curr Rheumatol Rep VL - 19 UR - https://doi.org/10.1007/s11926-017-0664-6 DO - 10.1007/s11926-017-0664-6 ID - Wolfe2017 ER - TY - JOUR AU - Aymonier, M. AU - Abed, S. AU - Boy, T. AU - Barazzutti, H. AU - Fournier, B. AU - Morand, J. J. PY - 2017 DA - 2017// TI - Dermatomyositis associated with anti-MDA5 antibodies and Pneumocystis pneumonia: two lethal cases JO - Ann Dermatol Venereol VL - 144 UR - https://doi.org/10.1016/j.annder.2016.09.677 DO - 10.1016/j.annder.2016.09.677 ID - Aymonier2017 ER - TY - STD TI - Stern A, Green H, Paul M, Vidal L, Leibovici L. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev. 2014:CD005590. ID - ref23 ER - TY - JOUR AU - Utsunomiya, M. AU - Dobashi, H. AU - Odani, T. AU - Saito, K. AU - Yokogawa, N. AU - Nagasaka, K. PY - 2017 DA - 2017// TI - Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial JO - Arthritis Res Ther. VL - 19 UR - https://doi.org/10.1186/s13075-016-1206-8 DO - 10.1186/s13075-016-1206-8 ID - Utsunomiya2017 ER - TY - JOUR AU - Ravn, P. AU - Munk, M. E. AU - Andersen, A. B. AU - Lundgren, B. AU - Nielsen, L. N. AU - Lillebaek, T. PY - 2004 DA - 2004// TI - Reactivation of tuberculosis during immunosuppressive treatment in a patient with a positive QuantiFERON-RD1 test JO - Scand J Infect Dis VL - 36 UR - https://doi.org/10.1080/00365540410015222 DO - 10.1080/00365540410015222 ID - Ravn2004 ER - TY - JOUR AU - Jick, S. S. AU - Lieberman, E. S. AU - Rahman, M. U. AU - Choi, H. K. PY - 2006 DA - 2006// TI - Glucocorticoid use, other associated factors, and the risk of tuberculosis JO - Arthritis Rheum VL - 55 UR - https://doi.org/10.1002/art.21705 DO - 10.1002/art.21705 ID - Jick2006 ER - TY - JOUR AU - Chan, M. J. AU - Wen, Y. H. AU - Huang, Y. B. AU - Chuang, H. Y. AU - Tain, Y. L. AU - Lily Wang, Y. C. PY - 2018 DA - 2018// TI - Risk of tuberculosis comparison in new users of anti-tumour necrosis factor and with existing disease-modifying antirheumatic drug therapy JO - J Clin Pharm Ther VL - 43 UR - https://doi.org/10.1111/jcpt.12644 DO - 10.1111/jcpt.12644 ID - Chan2018 ER - TY - JOUR AU - Kim, H. A. AU - Yoo, C. D. AU - Baek, H. J. AU - Lee, E. B. AU - Ahn, C. AU - Han, J. S. PY - 1998 DA - 1998// TI - Mycobacterium tuberculosis infection in a corticosteroid-treated rheumatic disease patient population JO - Clin Exp Rheumatol VL - 16 ID - Kim1998 ER - TY - BOOK PY - 2017 DA - 2017// TI - Ministry of Health ID - ref29 ER - TY - JOUR AU - Lam, C. S. AU - Tong, M. K. AU - Chan, K. M. AU - Siu, Y. P. PY - 2006 DA - 2006// TI - Disseminated strongyloidiasis: a retrospective study of clinical course and outcome JO - Eur J Clin Microbiol Infect Dis VL - 25 UR - https://doi.org/10.1007/s10096-005-0070-2 DO - 10.1007/s10096-005-0070-2 ID - Lam2006 ER - TY - JOUR AU - Santiago, M. AU - Leito, B. PY - 2009 DA - 2009// TI - Prevention of strongyloides hyperinfection syndrome: a rheumatological point of view JO - Eur J Intern Med VL - 20 UR - https://doi.org/10.1016/j.ejim.2009.09.001 DO - 10.1016/j.ejim.2009.09.001 ID - Santiago2009 ER - TY - JOUR AU - Davis, J. S. AU - Currie, B. J. AU - Fisher, D. A. AU - Huffam, S. E. AU - Anstey, N. M. AU - Price, R. N. PY - 2003 DA - 2003// TI - Prevention of opportunistic infections in immunosuppressed patients in the tropical top end of the Northern Territory JO - Commun Dis Intell Q Rep VL - 27 ID - Davis2003 ER - TY - JOUR AU - Shinjo, S. K. AU - Moraes, J. C. AU - Levy-Neto, M. AU - Aikawa, N. E. AU - Medeiros Ribeiro, A. C. AU - Schahin Saad, C. G. PY - 2012 DA - 2012// TI - Pandemic unadjuvanted influenza a (H1N1) vaccine in dermatomyositis and polymyositis: immunogenicity independent of therapy and no harmful effect in disease JO - Vaccine VL - 31 UR - https://doi.org/10.1016/j.vaccine.2012.10.063 DO - 10.1016/j.vaccine.2012.10.063 ID - Shinjo2012 ER - TY - JOUR AU - Guissa, V. R. AU - Pereira, R. M. AU - Sallum, A. M. AU - Aikawa, N. E. AU - Campos, L. M. AU - Silva, C. A. PY - 2012 DA - 2012// TI - Influenza a H1N1/2009 vaccine in juvenile dermatomyositis: reduced immunogenicity in patients under immunosuppressive therapy JO - Clin Exp Rheumatol VL - 30 ID - Guissa2012 ER - TY - JOUR AU - Bruhler, S. AU - Eperon, G. AU - Ribi, C. AU - Kyburz, D. AU - Gompel, F. AU - Visser, L. G. PY - 2015 DA - 2015// TI - Vaccination recommendations for adult patients with autoimmune inflammatory rheumatic diseases JO - Swiss Med Wkly VL - 145 ID - Bruhler2015 ER - TY - JOUR AU - Papadopoulou, D. AU - Sipsas, N. V. PY - 2014 DA - 2014// TI - Comparison of national clinical practice guidelines and recommendations on vaccination of adult patients with autoimmune rheumatic diseases JO - Rheumatol Int VL - 34 UR - https://doi.org/10.1007/s00296-013-2907-9 DO - 10.1007/s00296-013-2907-9 ID - Papadopoulou2014 ER - TY - JOUR AU - Assen, S. AU - Elkayam, O. AU - Agmon-Levin, N. AU - Cervera, R. AU - Doran, M. F. AU - Dougados, M. PY - 2011 DA - 2011// TI - Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European league against rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases JO - Autoimmun Rev VL - 10 UR - https://doi.org/10.1016/j.autrev.2010.12.003 DO - 10.1016/j.autrev.2010.12.003 ID - Assen2011 ER - TY - JOUR AU - Matz, E. L. AU - Hsieh, M. H. PY - 2017 DA - 2017// TI - Review of advances in uroprotective agents for cyclophosphamide and ifosfamide-induced hemorrhagic cystitis JO - Urology VL - 100 UR - https://doi.org/10.1016/j.urology.2016.07.030 DO - 10.1016/j.urology.2016.07.030 ID - Matz2017 ER - TY - JOUR AU - Cooper, C. AU - Bardin, T. AU - Brandi, M. L. AU - Cacoub, P. AU - Caminis, J. AU - Civitelli, R. PY - 2016 DA - 2016// TI - Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) JO - Aging Clin Exp Res VL - 28 UR - https://doi.org/10.1007/s40520-015-0522-1 DO - 10.1007/s40520-015-0522-1 ID - Cooper2016 ER - TY - JOUR AU - Lems, W. F. AU - Saag, K. PY - 2015 DA - 2015// TI - Bisphosphonates and glucocorticoid-induced osteoporosis: cons JO - Endocrine VL - 49 UR - https://doi.org/10.1007/s12020-015-0639-1 DO - 10.1007/s12020-015-0639-1 ID - Lems2015 ER - TY - JOUR AU - Bolosiu, H. D. AU - Man, L. AU - Rednic, S. PY - 1999 DA - 1999// TI - The effect of methylprednisolone pulse therapy in polymyositis/dermatomyositis JO - Adv Exp Med Biol VL - 455 UR - https://doi.org/10.1007/978-1-4615-4857-7_54 DO - 10.1007/978-1-4615-4857-7_54 ID - Bolosiu1999 ER - TY - JOUR AU - Winkelmann, R. K. AU - Mulder, D. W. AU - Lambert, E. H. AU - Howard, F. M. AU - Diessner, G. R. PY - 1968 DA - 1968// TI - Course of dermatomyositis-polymyositis: comparison of untreated and cortisone-treated patients JO - Mayo Clin Proc VL - 43 ID - Winkelmann1968 ER - TY - JOUR AU - Hoffman, G. S. AU - Franck, W. A. AU - Raddatz, D. A. AU - Stallones, L. PY - 1983 DA - 1983// TI - Presentation, treatment, and prognosis of idiopathic inflammatory muscle disease in a rural hospital JO - Am J Med VL - 75 UR - https://doi.org/10.1016/0002-9343(83)90344-3 DO - 10.1016/0002-9343(83)90344-3 ID - Hoffman1983 ER - TY - JOUR AU - Matsubara, S. AU - Hirai, S. AU - Sawa, Y. PY - 1997 DA - 1997// TI - Pulsed intravenous methylprednisolone therapy for inflammatory myopathies: evaluation of the effect by comparing two consecutive biopsies from the same muscle JO - J Neuroimmunol VL - 76 UR - https://doi.org/10.1016/S0165-5728(97)00033-7 DO - 10.1016/S0165-5728(97)00033-7 ID - Matsubara1997 ER - TY - JOUR AU - Naji, P. AU - Shahram, F. AU - Nadji, A. AU - Davatchi, F. PY - 2010 DA - 2010// TI - Effect of early treatment in polymyositis and dermatomyositis JO - Neurol India VL - 58 UR - https://doi.org/10.4103/0028-3886.60398 DO - 10.4103/0028-3886.60398 ID - Naji2010 ER - TY - JOUR AU - Souza, F. H. C. AU - Miossi, R. AU - Shinjo, S. K. PY - 2017 DA - 2017// TI - Necrotising myopathy associated with anti-signal recognition particle (anti-SRP) antibody JO - Clin Exp Rheumatol VL - 35 ID - Souza2017 ER - TY - JOUR AU - Pinhata, M. M. PY - 2015 DA - 2015// TI - Nascimento, Marie SK, Shinjo SK. Does previous corticosteroid treatment affect the inflammatory infiltrate found in polymyositis muscle biopsies? JO - Clin Exp Rheumatol VL - 33 ID - Pinhata2015 ER - TY - JOUR AU - Shinjo, S. K. AU - Nascimento, J. J. AU - Marie, S. K. PY - 2015 DA - 2015// TI - The effect of prior corticosteroid use in muscle biopsies from patients with dermatomyositis JO - Clin Exp Rheumatol VL - 33 ID - Shinjo2015 ER - TY - JOUR AU - Joffe, M. M. AU - Love, L. A. AU - Leff, R. L. AU - Fraser, D. D. AU - Targoff, I. N. AU - Hicks, J. E. PY - 1993 DA - 1993// TI - Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy JO - Am J Med VL - 94 UR - https://doi.org/10.1016/0002-9343(93)90148-I DO - 10.1016/0002-9343(93)90148-I ID - Joffe1993 ER - TY - STD TI - Fry CS, Nayeem SZ, Dillon EL, Sarkar PS, Tumurbaatar B, Urban RJ, et al. Glucocorticoids increase skeletal muscle NF-κB inducing kinase (NIK): links to muscle atrophy. Physiol Rep. 2016;4. ID - ref50 ER - TY - JOUR AU - Newman, E. D. AU - Scott, D. W. PY - 1995 DA - 1995// TI - The use of low-dose oral methotrexate in the treatment of polymyositis and dermatomyositis JO - J Clin Rheumatol VL - 1 UR - https://doi.org/10.1097/00124743-199504000-00007 DO - 10.1097/00124743-199504000-00007 ID - Newman1995 ER - TY - JOUR AU - Bunch, T. W. AU - Worthington, J. W. AU - Combs, J. J. AU - Ilstrup, D. M. AU - Engel, A. G. PY - 1980 DA - 1980// TI - Azathioprine with prednisone for polymyositis. A controlled, clinical trial JO - Ann Intern Med VL - 92 UR - https://doi.org/10.7326/0003-4819-92-3-365 DO - 10.7326/0003-4819-92-3-365 ID - Bunch1980 ER - TY - JOUR AU - Bunch, T. W. PY - 1981 DA - 1981// TI - Prednisone and azathioprine for polymyositis: long-term follow-up JO - Arthritis Rheum VL - 24 UR - https://doi.org/10.1002/art.1780240107 DO - 10.1002/art.1780240107 ID - Bunch1981 ER - TY - JOUR AU - Schiopu, E. AU - Phillips, K. AU - MacDonald, P. M. AU - Crofford, L. J. AU - Somers, E. C. PY - 2012 DA - 2012// TI - Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine JO - Arthritis Res Ther VL - 14 UR - https://doi.org/10.1186/ar3704 DO - 10.1186/ar3704 ID - Schiopu2012 ER - TY - JOUR AU - Yu, K. H. AU - Wu, Y. J. AU - Kuo, C. F. AU - See, L. C. AU - Shen, Y. M. AU - Chang, H. C. PY - 2011 DA - 2011// TI - Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases JO - Clin Rheumatol VL - 30 UR - https://doi.org/10.1007/s10067-011-1840-0 DO - 10.1007/s10067-011-1840-0 ID - Yu2011 ER - TY - JOUR AU - Cherin, P. AU - Piette, J. C. AU - Wechsler, B. AU - Bletry, O. AU - Ziza, J. M. AU - Laraki, R. PY - 1994 DA - 1994// TI - Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients JO - J Rheumatol VL - 21 ID - Cherin1994 ER - TY - JOUR AU - Göttfried, I. AU - Seeber, A. AU - Anegg, B. AU - Rieger, A. AU - Stingl, G. AU - Volc-Platzer, B. PY - 2000 DA - 2000// TI - High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels JO - Eur J Dermatol VL - 10 ID - Göttfried2000 ER - TY - JOUR AU - Anh-Tu Hoa, S. AU - Hudson, M. PY - 2017 DA - 2017// TI - Critical review of the role of intravenous immunoglobulins in idiopathic inflammatory myopathies JO - Semin Arthritis Rheum VL - 46 UR - https://doi.org/10.1016/j.semarthrit.2016.07.014 DO - 10.1016/j.semarthrit.2016.07.014 ID - Anh-Tu Hoa2017 ER - TY - JOUR AU - Oddis, C. V. AU - Sciurba, F. C. AU - Elmagd, K. A. AU - Starzl, T. E. PY - 1999 DA - 1999// TI - Tacrolimus in refractory polymyositis with interstitial lung disease JO - Lancet VL - 353 UR - https://doi.org/10.1016/S0140-6736(99)01927-3 DO - 10.1016/S0140-6736(99)01927-3 ID - Oddis1999 ER - TY - JOUR AU - Chang, H. K. AU - Lee, D. H. PY - 2003 DA - 2003// TI - Successful combination therapy of cyclosporine and methotrexate for refractory polymyositis with anti-Jo-1 antibody: a case report JO - J Korean Med Sci VL - 18 UR - https://doi.org/10.3346/jkms.2003.18.1.131 DO - 10.3346/jkms.2003.18.1.131 ID - Chang2003 ER - TY - JOUR AU - Mitsunaka, H. AU - Tokuda, M. AU - Hiraishi, T. AU - Dobashi, H. AU - Takahara, J. PY - 2000 DA - 2000// TI - Combined use of cyclosporine a and methotrexate in refractory polymyositis JO - Scand J Rheumatol VL - 29 UR - https://doi.org/10.1080/030097400750002102 DO - 10.1080/030097400750002102 ID - Mitsunaka2000 ER - TY - JOUR AU - Qushmaq, K. A. AU - Chalmers, A. AU - Esdaile, J. M. PY - 2000 DA - 2000// TI - Cyclosporin a in the treatment of refractory adult polymyositis/dermatomyositis: population based experience in 6 patients and literature review JO - J Rheumatol VL - 27 ID - Qushmaq2000 ER - TY - JOUR AU - Villalba, L. AU - Hicks, J. E. AU - Adams, E. M. AU - Sherman, J. B. AU - Gourley, M. F. AU - Leff, R. L. PY - 1998 DA - 1998// TI - Treatment of refractory myositis: a randomized crossover study of two new cytotoxic regimens JO - Arthritis Rheum VL - 41 UR - https://doi.org/3.0.CO;2-X DO - 3.0.CO;2-X ID - Villalba1998 ER - TY - JOUR AU - Nakashima, S. AU - Mori, M. AU - Miyamae, T. AU - Ito, S. AU - Ibe, M. AU - Aihara, Y. PY - 2002 DA - 2002// TI - Intravenous cyclophosphamide pulse therapy for refractory juvenile dermatomyositis JO - Ryumachi VL - 42 ID - Nakashima2002 ER - TY - JOUR AU - Hirano, F. AU - Tanaka, H. AU - Nomura, Y. AU - Matsui, T. AU - Makino, Y. AU - Fukawa, E. PY - 1993 DA - 1993// TI - Successful treatment of refractory polymyositis with pulse intravenous cyclophosphamide and low-dose weekly oral methotrexate therapy JO - Intern Med VL - 32 UR - https://doi.org/10.2169/internalmedicine.32.749 DO - 10.2169/internalmedicine.32.749 ID - Hirano1993 ER - TY - JOUR AU - Edge, J. C. AU - Outland, J. D. AU - Dempsey, J. R. AU - Callen, J. P. PY - 2006 DA - 2006// TI - Mycophenolate mofetil as an effective corticosteroid sparing therapy for recalcitrant dermatomyositis JO - Arch Dermatol VL - 142 UR - https://doi.org/10.1001/archderm.142.1.65 DO - 10.1001/archderm.142.1.65 ID - Edge2006 ER - TY - JOUR AU - Souza, R. C. AU - Souza, F. H. C. AU - Miossi, R. AU - Shinjo, S. K. PY - 2017 DA - 2017// TI - Efficacty and safety of leflunomide as na adjuvante drug in refractory dermatomyositis with primarily cutaneous activity JO - Clin Exp Rheumatol VL - 35 ID - Souza2017 ER - TY - JOUR AU - Saito, E. AU - Koike, T. AU - Hashimoto, H. AU - Miyasaka, N. AU - Ikeda, Y. AU - Hara, M. PY - 2008 DA - 2008// TI - Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis JO - Mod Rheumatol VL - 18 UR - https://doi.org/10.3109/s10165-007-0013-0 DO - 10.3109/s10165-007-0013-0 ID - Saito2008 ER - TY - JOUR AU - Dalakas, M. C. AU - Illa, I. AU - Dambrosia, J. M. AU - Soueidan, S. A. AU - Stein, D. P. AU - Otero, C. PY - 1993 DA - 1993// TI - A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis JO - N Engl J Med VL - 329 UR - https://doi.org/10.1056/NEJM199312303292704 DO - 10.1056/NEJM199312303292704 ID - Dalakas1993 ER - TY - JOUR AU - Cherin, P. AU - Pelletier, S. AU - Teixeira, A. AU - Laforet, P. AU - Genereau, T. AU - Simon, A. PY - 2002 DA - 2002// TI - Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients JO - Arthritis Rheum VL - 46 UR - https://doi.org/10.1002/art.10053 DO - 10.1002/art.10053 ID - Cherin2002 ER - TY - JOUR AU - Wendling, D. AU - Prati, C. AU - Ornetti, P. AU - Toussirot, E. AU - Streit, G. PY - 2007 DA - 2007// TI - Anti TNF-alpha treatment of a refractory polymyositis JO - Rev Med Interne VL - 28 UR - https://doi.org/10.1016/j.revmed.2006.12.001 DO - 10.1016/j.revmed.2006.12.001 ID - Wendling2007 ER - TY - JOUR AU - Dastmalchi, M. AU - Grundtman, C. AU - Alexanderson, H. AU - Mavragani, C. P. AU - Einarsdottir, H. AU - Helmers, S. B. PY - 2008 DA - 2008// TI - A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies JO - Ann Rheum Dis VL - 67 UR - https://doi.org/10.1136/ard.2007.077974 DO - 10.1136/ard.2007.077974 ID - Dastmalchi2008 ER - TY - JOUR AU - Iannone, F. AU - Scioscia, C. AU - Falappone, P. C. AU - Covelli, M. AU - Lapadula, G. PY - 2006 DA - 2006// TI - Use of etanercept in the treatment of dermatomyositis: a case series JO - J Rheumatol VL - 33 ID - Iannone2006 ER - TY - JOUR AU - Amato, A. A. AU - Tawil, R. AU - Kissel, J. AU - Barohn, R. AU - McDermott, M. P. AU - Pandya, S. PY - 2011 DA - 2011// TI - A randomized, pilot trial of etanercept in dermatomyositis JO - Ann Neurol VL - 70 UR - https://doi.org/10.1002/ana.22607 DO - 10.1002/ana.22607 ID - Amato2011 ER - TY - JOUR AU - Tjärnlund, A. AU - Tang, Q. AU - Wick, C. AU - Dastmalchi, M. AU - Mann, H. AU - Tomasová Studýnková, J. PY - 2018 DA - 2018// TI - Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial JO - Ann Rheum Dis VL - 77 UR - https://doi.org/10.1136/annrheumdis-2017-211751 DO - 10.1136/annrheumdis-2017-211751 ID - Tjärnlund2018 ER - TY - JOUR AU - Narazaki, M. AU - Hagihara, K. AU - Shima, Y. AU - Ogata, A. AU - Kishimoto, T. AU - Tanaka, T. PY - 2011 DA - 2011// TI - Therapeutic effect of tocilizumab on two patients with polymyositis JO - Rheumatology (Oxford) VL - 50 UR - https://doi.org/10.1093/rheumatology/ker152 DO - 10.1093/rheumatology/ker152 ID - Narazaki2011 ER - TY - JOUR AU - Mahler, E. A. AU - Blom, M. AU - Voermans, N. C. AU - Engelen, B. G. AU - Riel, P. L. AU - Vonk, M. C. PY - 2011 DA - 2011// TI - Rituximab treatment in patients with refractory inflammatory myopathies JO - Rheumatology (Oxford) VL - 50 UR - https://doi.org/10.1093/rheumatology/ker088 DO - 10.1093/rheumatology/ker088 ID - Mahler2011 ER - TY - JOUR AU - Mok, C. C. AU - Ho, L. Y. AU - To, C. H. PY - 2007 DA - 2007// TI - Rituximab for refractory polymyositis: an open-label prospective study JO - J Rheumatol VL - 34 ID - Mok2007 ER - TY - JOUR AU - Noss, E. H. AU - Hausner-Sypek, D. L. AU - Weinblatt, M. E. PY - 2006 DA - 2006// TI - Rituximab as therapy for refractory polymyositis and dermatomyositis JO - J Rheumatol VL - 33 ID - Noss2006 ER - TY - JOUR AU - Sánchez-Fernández, S. Á. AU - Carrasco Fernández, J. A. AU - Rojas Vargas, L. M. PY - 2013 DA - 2013// TI - Efficacy of rituximab in dermatomyositis and polymyositis refractory to conventional therapy JO - Reumatol Clin VL - 9 UR - https://doi.org/10.1016/j.reuma.2012.02.007 DO - 10.1016/j.reuma.2012.02.007 ID - Sánchez-Fernández2013 ER - TY - JOUR AU - Frikha, F. AU - Rigolet, A. AU - Behin, A. AU - Fautrel, B. AU - Herson, S. AU - Benveniste, O. PY - 2009 DA - 2009// TI - Efficacy of rituximab in refractory and relapsing myositis with anti-Jo-1 antibodies: a report of two cases JO - Rheumatology (Oxford) VL - 48 UR - https://doi.org/10.1093/rheumatology/kep147 DO - 10.1093/rheumatology/kep147 ID - Frikha2009 ER - TY - JOUR AU - Unger, L. AU - Kampf, S. AU - Lüthke, K. AU - Aringer, M. PY - 2014 DA - 2014// TI - Rituximab therapy in patients with refractory dermatomyositis or polymyositis: differential effects in a real-life population JO - Rheumatology (Oxford) VL - 53 UR - https://doi.org/10.1093/rheumatology/keu024 DO - 10.1093/rheumatology/keu024 ID - Unger2014 ER - TY - JOUR AU - Levine, T. D. PY - 2005 DA - 2005// TI - Rituximab in the treatment of dermatomyositis: an open-label pilot study JO - Arthritis Rheum VL - 52 UR - https://doi.org/10.1002/art.20849 DO - 10.1002/art.20849 ID - Levine2005 ER - TY - JOUR AU - Lambotte, O. AU - Kotb, R. AU - Maigne, G. AU - Blanc, F. X. AU - Goujard, C. AU - Delfraissy, J. F. PY - 2005 DA - 2005// TI - Efficacy of rituximab in refractory polymyositis JO - J Rheumatol VL - 32 ID - Lambotte2005 ER - TY - JOUR AU - Oddis, C. V. AU - Reed, A. M. AU - Aggarwal, R. AU - Rider, L. G. AU - Ascherman, D. P. AU - Levesque, M. C. PY - 2013 DA - 2013// TI - Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial JO - Arthritis Rheum VL - 65 UR - https://doi.org/10.1002/art.37754 DO - 10.1002/art.37754 ID - Oddis2013 ER - TY - JOUR AU - Reed, A. M. AU - Crowson, C. S. AU - Hein, M. AU - Padilla, C. L. AU - Olazagasti, J. M. AU - Aggarwal, R. PY - 2015 DA - 2015// TI - Biologic predictors of clinical improvement in rituximab-treated refractory myositis JO - BMC Musculoskelet Disord VL - 16 UR - https://doi.org/10.1186/s12891-015-0710-3 DO - 10.1186/s12891-015-0710-3 ID - Reed2015 ER - TY - JOUR AU - Allenbach, Y. AU - Guiguet, M. AU - Rigolet, A. AU - Marie, I. AU - Hachulla, E. AU - Drouot, L. PY - 2015 DA - 2015// TI - Efficacy of rituximab in refractory inflammatory myopathies associated with anti-synthetase auto-antibodies: an open-label, phase II trial JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0133702 DO - 10.1371/journal.pone.0133702 ID - Allenbach2015 ER - TY - JOUR AU - Kooi, A. J. AU - Visser, M. PY - 2014 DA - 2014// TI - Idiopathic inflammatory myopathies JO - Handb Clin Neurol VL - 119 UR - https://doi.org/10.1016/B978-0-7020-4086-3.00032-1 DO - 10.1016/B978-0-7020-4086-3.00032-1 ID - Kooi2014 ER - TY - JOUR AU - Dalakas, M. C. PY - 2015 DA - 2015// TI - Inflammatory muscle diseases JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMra1402225 DO - 10.1056/NEJMra1402225 ID - Dalakas2015 ER - TY - JOUR AU - Nzeusseu, A. AU - Brion, F. AU - Lefèbvre, C. AU - Knoops, P. AU - Devogelaer, J. P. PY - 1999 DA - 1999// TI - Functional outcome of myositis patients: can a low-dose glucocorticoid regimen achieve good functional results? JO - Clin Exp Rheumatol VL - 17 ID - Nzeusseu1999 ER - TY - JOUR AU - Vlekkert, J. AU - Hoogendijk, J. E. AU - Haan, R. J. AU - Algra, A. AU - Tweel, I. AU - Pol, W. L. PY - 2010 DA - 2010// TI - Dexa myositis trial. Oral dexamethasone pulse therapy versus daily prednisolone in sub-acute onset myositis, a randomized clinical trial JO - Neuromuscul Disord VL - 20 UR - https://doi.org/10.1016/j.nmd.2010.03.011 DO - 10.1016/j.nmd.2010.03.011 ID - Vlekkert2010 ER - TY - JOUR AU - Uchino, M. AU - Yamashita, S. AU - Uchino, K. AU - Hara, A. AU - Koide, T. AU - Suga, T. PY - 2012 DA - 2012// TI - Long-term outcome of polymyositis treated with high single-dose alternate-day prednisolone therapy JO - Eur Neurol VL - 68 UR - https://doi.org/10.1159/000338474 DO - 10.1159/000338474 ID - Uchino2012 ER - TY - JOUR AU - Seshadri, R. AU - Feldman, B. M. AU - Ilowite, N. AU - Cawkwell, G. AU - Pachman, L. M. PY - 2008 DA - 2008// TI - The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysis JO - Arthritis Rheum VL - 59 UR - https://doi.org/10.1002/art.23829 DO - 10.1002/art.23829 ID - Seshadri2008 ER - TY - JOUR AU - Raghu, P. AU - Manadan, A. M. AU - Schmukler, J. AU - Mathur, T. AU - Block, J. A. PY - 2015 DA - 2015// TI - Pulse dose methylprednisolone therapy for adult idiopathic inflammatory myopathy JO - Am J Ther VL - 22 UR - https://doi.org/10.1097/MJT.0000000000000175 DO - 10.1097/MJT.0000000000000175 ID - Raghu2015 ER - TY - JOUR AU - Mathur, T. AU - Manadan, A. M. AU - Thiagarajan, S. AU - Hota, B. AU - Block, J. A. PY - 2015 DA - 2015// TI - Corticosteroid monotherapy is usually insufficient treatment for idiopathic inflammatory myopathy JO - Am J Ther VL - 22 UR - https://doi.org/10.1097/MJT.0b013e3182987983 DO - 10.1097/MJT.0b013e3182987983 ID - Mathur2015 ER - TY - JOUR AU - Mosca, M. AU - Neri, R. AU - Pasero, G. AU - Bombardieri, S. PY - 2000 DA - 2000// TI - Treatment of the idiopathic inflammatory myopathies: a retrospective analysis of 63 Caucasian patients longitudinally followed at a single center JO - Clin Exp Rheumatol VL - 18 ID - Mosca2000 ER - TY - JOUR AU - Bronner, I. M. AU - Meulen, M. F. AU - Visser, M. AU - Kalmijn, S. AU - Venrooij, W. J. AU - Voskuyl, A. E. PY - 2006 DA - 2006// TI - Long-term outcome in polymyositis and dermatomyositis JO - Ann Rheum Dis VL - 65 UR - https://doi.org/10.1136/ard.2005.045690 DO - 10.1136/ard.2005.045690 ID - Bronner2006 ER - TY - JOUR AU - Marie, I. AU - Hachulla, E. AU - Hatron, P. Y. AU - Hellot, M. F. AU - Levesque, H. AU - Devulder, B. PY - 2001 DA - 2001// TI - Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis JO - J Rheumatol VL - 28 ID - Marie2001 ER - TY - JOUR AU - Vencovsk, J. AU - Jarosov, K. AU - Machcek, S. AU - Studnkov, J. AU - Kafkov, J. AU - Bartunková, J. PY - 2000 DA - 2000// TI - Cyclosporine a versus methotrexate in the treatment of polymyositis and dermatomyositis JO - Scand J Rheumatol VL - 29 UR - https://doi.org/10.1080/030097400750001897 DO - 10.1080/030097400750001897 ID - Vencovsk2000 ER - TY - JOUR AU - Ibrahim, F. AU - Choy, E. AU - Gordon, P. AU - Dor, C. J. AU - Hakim, A. AU - Kitas, G. PY - 2015 DA - 2015// TI - Second-line agents in myositis: 1-year factorial trial of additional immunosuppression in patients who have partially responded to steroids JO - Rheumatology (Oxford) VL - 54 UR - https://doi.org/10.1093/rheumatology/keu442 DO - 10.1093/rheumatology/keu442 ID - Ibrahim2015 ER - TY - JOUR AU - Pisoni, C. N. AU - Cuadrado, M. J. AU - Khamashta, M. A. AU - Hughes, G. R. AU - D'Cruz, D. P. PY - 2007 DA - 2007// TI - Mycophenolate mofetil treatment in resistant myositis JO - Rheumatology (Oxford) VL - 46 UR - https://doi.org/10.1093/rheumatology/kel336 DO - 10.1093/rheumatology/kel336 ID - Pisoni2007 ER - TY - JOUR AU - Majithia, V. AU - Harisdangkul, V. PY - 2005 DA - 2005// TI - Mycophenolate mofetil (CellCept): an alternative therapy for autoimmune inflammatory myopathy JO - Rheumatology (Oxford) VL - 44 UR - https://doi.org/10.1093/rheumatology/keh499 DO - 10.1093/rheumatology/keh499 ID - Majithia2005 ER - TY - JOUR AU - Dagher, R. AU - Desjonqures, M. AU - Duquesne, A. AU - Quartier, P. AU - Bader-Meunier, B. AU - Fischbach, M. PY - 2012 DA - 2012// TI - Mycophenolate mofetil in juvenile dermatomyositis: a case series JO - Rheumatol Int VL - 32 UR - https://doi.org/10.1007/s00296-010-1653-5 DO - 10.1007/s00296-010-1653-5 ID - Dagher2012 ER - TY - JOUR AU - Mira-Avendano, I. C. AU - Parambil, J. G. AU - Yadav, R. AU - Arrossi, V. AU - Xu, M. AU - Chapman, J. T. PY - 2013 DA - 2013// TI - A retrospective review of clinical features and treatment outcomes in steroid resistant interstitial lung disease from polymyositis / dermatomyositis JO - Respir Med VL - 107 UR - https://doi.org/10.1016/j.rmed.2013.02.015 DO - 10.1016/j.rmed.2013.02.015 ID - Mira-Avendano2013 ER - TY - JOUR AU - Morganroth, P. A. AU - Kreider, M. E. AU - Werth, V. P. PY - 2010 DA - 2010// TI - Mycophenolate mofetil for interstitial lung disease in dermatomyositis JO - Arthritis Care Res (Hoboken) VL - 62 UR - https://doi.org/10.1002/acr.20212 DO - 10.1002/acr.20212 ID - Morganroth2010 ER - TY - JOUR AU - Cea, G. AU - Bendahan, D. AU - Manners, D. AU - Hilton-Jones, D. AU - Lodi, R. AU - Styles, P. PY - 2002 DA - 2002// TI - Reduced oxidative phosphorylation and proton efflux suggest reduced capillary blood supply in skeletal muscle of patients with dermatomyositis and polymyositis: a quantitative 31P - magnetic resonance spectroscopy and MRI study JO - Brain VL - 125 UR - https://doi.org/10.1093/brain/awf163 DO - 10.1093/brain/awf163 ID - Cea2002 ER - TY - JOUR AU - Englund, P. AU - Nennesmo, I. AU - Klareskog, L. AU - Lundberg, I. E. PY - 2002 DA - 2002// TI - Interleukin-1 alpha expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients: important pathogenic features independent of inflammatory cell clusters in muscle tissue JO - Arthritis Rheum VL - 46 UR - https://doi.org/10.1002/art.10140 DO - 10.1002/art.10140 ID - Englund2002 ER - TY - JOUR AU - Loell, I. AU - Lundberg, I. E. PY - 2011 DA - 2011// TI - Can muscle regeneration fail in chronic inflammation: a weakness in inflammatory myopathies? JO - J Intern Med VL - 269 UR - https://doi.org/10.1111/j.1365-2796.2010.02334.x DO - 10.1111/j.1365-2796.2010.02334.x ID - Loell2011 ER - TY - JOUR AU - Varjú, C. AU - Pethö, E. AU - Kutas, R. AU - Czirják, L. PY - 2003 DA - 2003// TI - The effect of physical exercise following acute disease exacerbation in patients with dermato/polymyositis JO - Clin Rehabil VL - 17 UR - https://doi.org/10.1191/0269215503cr572oa DO - 10.1191/0269215503cr572oa ID - Varjú2003 ER - TY - JOUR AU - Bertolucci, F. AU - Neri, R. AU - Dalise, S. AU - Venturi, M. AU - Rossi, B. AU - Crisari, C. PY - 2014 DA - 2014// TI - Abnormal lactate levels in patients with polymyositis and dermatomyositis: the benefits of a specific rehabilitative program JO - Eur J Phys Rehabil Med VL - 50 ID - Bertolucci2014 ER - TY - JOUR AU - Wiesinger, G. F. AU - Quittan, M. AU - Aringer, M. AU - Seeber, A. AU - Volc-Platzer, B. AU - Smolen, J. PY - 1998 DA - 1998// TI - Improvement of physical fitness and muscle strength in polymyositis/dermatomyositis patients by a training programme JO - Br J Rheumatol VL - 37 UR - https://doi.org/10.1093/rheumatology/37.2.196 DO - 10.1093/rheumatology/37.2.196 ID - Wiesinger1998 ER - TY - JOUR AU - Hicks, J. E. AU - Miller, F. AU - Plotz, P. AU - Chen, T. H. AU - Gerber, L. PY - 1993 DA - 1993// TI - Isometric exercise increases strength and does not produce sustained creatinine phosphokinase increases in a patient with polymyositis JO - J Rheumatol VL - 20 ID - Hicks1993 ER - TY - JOUR AU - Escalante, A. AU - Miller, L. AU - Beardmore, T. D. PY - 1993 DA - 1993// TI - Resistive exercise in the rehabilitation of polymyositis/dermatomyositis JO - J Rheumatol VL - 20 ID - Escalante1993 ER - TY - JOUR AU - Nader, G. A. AU - Lundberg, I. E. PY - 2009 DA - 2009// TI - Exercise as an anti-inflammatory intervention to combat inflammatory diseases of muscle JO - Curr Opin Rheumatol VL - 21 UR - https://doi.org/10.1097/BOR.0b013e3283319d53 DO - 10.1097/BOR.0b013e3283319d53 ID - Nader2009 ER - TY - JOUR AU - Nader, G. A. AU - Dastmalchi, M. AU - Alexanderson, H. AU - Grundtman, C. AU - Gernapudi, R. AU - Esbjörnsson, M. PY - 2010 DA - 2010// TI - A longitudinal, integrated, clinical, histological and mRNA profiling study of resistance exercise in myositis JO - Mol Med VL - 16 UR - https://doi.org/10.2119/molmed.2010.00016 DO - 10.2119/molmed.2010.00016 ID - Nader2010 ER - TY - JOUR AU - Munters, L. A. AU - Loell, I. AU - Ossipova, E. AU - Raouf, J. AU - Dastmalchi, M. AU - Lindroos, E. PY - 2016 DA - 2016// TI - Endurance exercise improves molecular pathways of aerobic metabolism in patients with myositis JO - Arthritis Rheumatol VL - 68 UR - https://doi.org/10.1002/art.39624 DO - 10.1002/art.39624 ID - Munters2016 ER - TY - JOUR AU - Boehler, J. F. AU - Hogarth, M. W. AU - Barberio, M. D. AU - Novak, J. S. AU - Ghimbovschi, S. AU - Brown, K. J. PY - 2017 DA - 2017// TI - Effect of endurance exercise on microRNAs in myositis skeletal muscle - a randomized controlled study JO - PLoS One VL - 12 UR - https://doi.org/10.1371/journal.pone.0183292 DO - 10.1371/journal.pone.0183292 ID - Boehler2017 ER - TY - JOUR AU - Alexanderson, H. AU - Munters, L. A. AU - Dastmalchi, M. AU - Loell, I. AU - Heimbürger, M. AU - Opava, C. H. PY - 2014 DA - 2014// TI - Resistive home exercise in patients with recent-onset polymyositis and dermatomyositis - a randomized controlled single-blinded study with a 2-year followup JO - J Rheumatol VL - 41 UR - https://doi.org/10.3899/jrheum.131145 DO - 10.3899/jrheum.131145 ID - Alexanderson2014 ER - TY - JOUR AU - Alemo Munters, L. AU - Dastmalchi, M. AU - Katz, A. AU - Esbjörnsson, M. AU - Loell, I. AU - Hanna, B. PY - 2013 DA - 2013// TI - Improved exercise performance and increased aerobic capacity after endurance training of patients with stable polymyositis and dermatomyositis JO - Arthritis Res Ther. VL - 15 UR - https://doi.org/10.1186/ar4263 DO - 10.1186/ar4263 ID - Alemo Munters2013 ER - TY - JOUR AU - Alemo Munters, L. AU - Dastmalchi, M. AU - Andgren, V. AU - Emilson, C. AU - Bergegård, J. AU - Regardt, M. PY - 2013 DA - 2013// TI - Improvement in health and possible reduction in disease activity using endurance exercise in patients with established polymyositis and dermatomyositis: a multicenter randomized controlled trial with a 1-year open extension follow-up JO - Arthritis Care Res (Hoboken) VL - 65 UR - https://doi.org/10.1002/acr.22068 DO - 10.1002/acr.22068 ID - Alemo Munters2013 ER - TY - JOUR AU - Tiffreau, V. AU - Rannou, F. AU - Kopciuch, F. AU - Hachulla, E. AU - Mouthon, L. AU - Thoumie, P. PY - 2017 DA - 2017// TI - Post rehabilitation functional improvements in patients with inflammatory myopathies: the results of a randomized controlle trial JO - Arch Phys Med Rehabil VL - 98 UR - https://doi.org/10.1016/j.apmr.2016.09.125 DO - 10.1016/j.apmr.2016.09.125 ID - Tiffreau2017 ER - TY - JOUR AU - López De Padilla, C. M. AU - Crowson, C. S. AU - Hein, M. S. AU - Strausbauch, M. A. AU - Aggarwal, R. AU - Levesque, M. C. PY - 2015 DA - 2015// TI - Interferon-regulated chemokine score associated with improvement in disease activity in refractory myositis patients treated with rituximab JO - Clin Exp Rheumatol VL - 33 ID - López De Padilla2015 ER - TY - JOUR AU - Gono, T. AU - Kaneko, H. AU - Kawaguchi, Y. AU - Hanaoka, M. AU - Kataoka, S. AU - Kuwana, M. PY - 2014 DA - 2014// TI - Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease JO - Rheumatology (Oxford) VL - 53 UR - https://doi.org/10.1093/rheumatology/keu258 DO - 10.1093/rheumatology/keu258 ID - Gono2014 ER - TY - JOUR AU - Olazagasti, J. M. AU - Niewold, T. B. AU - Reed, A. M. PY - 2015 DA - 2015// TI - Immunological biomarkers in dermatomyositis JO - Curr Rheumatol Rep VL - 17 UR - https://doi.org/10.1007/s11926-015-0543-y DO - 10.1007/s11926-015-0543-y ID - Olazagasti2015 ER - TY - JOUR AU - Badrising, U. A. AU - Tsonaka, R. AU - Hiller, M. AU - Niks, E. H. AU - Evangelista, T. AU - Lochmüller, H. PY - 2017 DA - 2017// TI - Cytokine profiling of serum allows monitoring of disease progression in inclusion body myositis JO - J Neuromuscul Dis VL - 4 UR - https://doi.org/10.3233/JND-170234 DO - 10.3233/JND-170234 ID - Badrising2017 ER - TY - JOUR AU - Krystufková, O. AU - Vallerskog, T. AU - Helmers, S. B. AU - Mann, H. AU - Putová, I. AU - Belácek, J. PY - 2009 DA - 2009// TI - Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies JO - Ann Rheum Dis VL - 68 UR - https://doi.org/10.1136/ard.2008.091405 DO - 10.1136/ard.2008.091405 ID - Krystufková2009 ER - TY - JOUR AU - Reed, A. M. AU - Peterson, E. AU - Bilgic, H. AU - Ytterberg, S. R. AU - Amin, S. AU - Hein, M. S. PY - 2012 DA - 2012// TI - Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course JO - Arthritis Rheum VL - 64 UR - https://doi.org/10.1002/art.34659 DO - 10.1002/art.34659 ID - Reed2012 ER - TY - JOUR AU - Kobayashi, N. AU - Kobayashi, I. AU - Mori, M. AU - Sato, S. AU - Iwata, N. AU - Shiguemura, T. PY - 2015 DA - 2015// TI - Increased serum B cell activating factor and a proliferation-inducing ligand are associated with interstitial lung disease in patients with juvenile dermatomyositis JO - J Rheumatol VL - 42 UR - https://doi.org/10.3899/jrheum.140977 DO - 10.3899/jrheum.140977 ID - Kobayashi2015 ER - TY - JOUR AU - Kubo, M. AU - Ihn, H. AU - Yamane, K. AU - Kikuchi, K. AU - Yazawa, N. AU - Soma, Y. PY - 2000 DA - 2000// TI - Serum KL-6 in adult patients with polymyositis and dermatomyositis JO - Rheumatology (Oxford) VL - 39 UR - https://doi.org/10.1093/rheumatology/39.6.632 DO - 10.1093/rheumatology/39.6.632 ID - Kubo2000 ER - TY - JOUR AU - Fathi, M. AU - Barbasso Helmers, S. AU - Lundberg, I. E. PY - 2012 DA - 2012// TI - KL-6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis JO - J Intern Med VL - 271 UR - https://doi.org/10.1111/j.1365-2796.2011.02459.x DO - 10.1111/j.1365-2796.2011.02459.x ID - Fathi2012 ER - TY - JOUR AU - Chen, F. AU - Lu, X. AU - Shu, X. AU - Peng, Q. AU - Tian, X. AU - Wang, G. PY - 2015 DA - 2015// TI - Predictive value of serum markers for the development of interstitial lung disease in patients with polymyositis and dermatomyositis: a comparative and prospective study JO - Intern Med J VL - 45 UR - https://doi.org/10.1111/imj.12754 DO - 10.1111/imj.12754 ID - Chen2015 ER - TY - JOUR AU - Nistala, K. AU - Varsani, H. AU - Wittkowski, H. AU - Vogl, T. AU - Krol, P. AU - Shah, V. PY - 2013 DA - 2013// TI - Myeloid related protein induces muscle derived inflammatory mediators in juvenile dermatomyositis JO - Arthritis Res Ther. VL - 15 UR - https://doi.org/10.1186/ar4311 DO - 10.1186/ar4311 ID - Nistala2013 ER - TY - JOUR AU - Olazagasti, J. M. AU - Hein, M. AU - Crowson, C. S. AU - Padilla, C. L. AU - Peterson, E. AU - Baechler, E. C. PY - 2015 DA - 2015// TI - Adipokine gene expression in peripheral blood of adult and juvenile dermatomyositis patients and their relation to clinical parameters and disease activity measures JO - J Inflamm (Lond) VL - 12 UR - https://doi.org/10.1186/s12950-015-0075-2 DO - 10.1186/s12950-015-0075-2 ID - Olazagasti2015 ER - TY - JOUR AU - Bellutti Enders, F. AU - Wijk, F. AU - Scholman, R. AU - Hofer, M. AU - Prakken, B. J. AU - Royen-Kerkhof, A. AU - Jager, W. PY - 2014 DA - 2014// TI - Correlation of CXCL10, tumor necrosis factor receptor type II, and galectin 9 with disease activity in juvenile dermatomyositis JO - Arthritis Rheumatol. VL - 66 UR - https://doi.org/10.1002/art.38676 DO - 10.1002/art.38676 ID - Bellutti Enders2014 ER - TY - JOUR AU - McHugh, N. J. AU - Tansley, S. L. PY - 2018 DA - 2018// TI - Autoantibodies in myositis JO - Nat Rev Rheumatol VL - 14 UR - https://doi.org/10.1038/nrrheum.2018.56 DO - 10.1038/nrrheum.2018.56 ID - McHugh2018 ER - TY - JOUR AU - Aggarwal, R. AU - Oddis, C. V. AU - Goudeau, D. AU - Koontz, D. AU - Qi, Z. AU - Reed, A. M. PY - 2016 DA - 2016// TI - Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab JO - Rheumatology (Oxford) VL - 55 UR - https://doi.org/10.1093/rheumatology/kev444 DO - 10.1093/rheumatology/kev444 ID - Aggarwal2016 ER - TY - JOUR AU - Ishizuka, M. AU - Watanabe, R. AU - Ishii, T. AU - Machiyama, T. AU - Akita, K. AU - Fujita, Y. PY - 2016 DA - 2016// TI - Long-term follow-up of 124 patients with polymyositis and dermatomyositis: statistical analysis of prognostic factors JO - Mod Rheumatol VL - 26 UR - https://doi.org/10.3109/14397595.2015.1054081 DO - 10.3109/14397595.2015.1054081 ID - Ishizuka2016 ER - TY - JOUR AU - Dalakas, M. C. PY - 2003 DA - 2003// TI - Polymyositis and dermatomyositis JO - Lancet VL - 362 UR - https://doi.org/10.1016/S0140-6736(03)14368-1 DO - 10.1016/S0140-6736(03)14368-1 ID - Dalakas2003 ER - TY - JOUR AU - Nozaki, K. AU - Pestronk, A. PY - 2009 DA - 2009// TI - High aldolase with normal creatine kinase in serum predicts a myopathy with perimysial pathology JO - J Neurol Neurosurg Psychiatry VL - 80 UR - https://doi.org/10.1136/jnnp.2008.161448 DO - 10.1136/jnnp.2008.161448 ID - Nozaki2009 ER - TY - JOUR AU - Rider, L. G. AU - Giannini, E. H. AU - Harris-Love, M. AU - Joe, G. AU - Isenberg, D. AU - Pilkington, C. PY - 2003 DA - 2003// TI - Defining clinical improvement in adult and juvenile myositis JO - J Rheumatol VL - 30 ID - Rider2003 ER - TY - JOUR AU - Oddis, C. V. AU - Rider, L. G. AU - Reed, A. M. AU - Ruperto, N. AU - Brunner, H. I. AU - Koneru, B. PY - 2005 DA - 2005// TI - International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies JO - Arthritis Rheum VL - 52 UR - https://doi.org/10.1002/art.21291 DO - 10.1002/art.21291 ID - Oddis2005 ER - TY - JOUR AU - Aggarwal, R. AU - Rider, L. AU - Ruperto, N. AU - Bayat, N. AU - Erman, B. AU - Feldman, B. M. PY - 2017 DA - 2017// TI - 2016 American College of Rheumatology (ACR)- European league against rheumatism (EULAR) criteria for minimal, moderate and major clinical response for adult dermatomyositis and polymyositis: an international myositis assessment and clinical studies group/ pediatric rheumatology international trials organization collaborative initiative JO - Ann Rheum Dis VL - 76 UR - https://doi.org/10.1136/annrheumdis-2017-211400 DO - 10.1136/annrheumdis-2017-211400 ID - Aggarwal2017 ER - TY - JOUR AU - Abdul-Aziz, R. AU - Yu, C. Y. AU - Adler, B. AU - Bout-Tabaku, S. AU - Lintner, K. E. AU - Moore-Clingenpeel, M. PY - 2017 DA - 2017// TI - Muscle MRI at the time of questionable disease flares in juvenile dermatomyositis (JDM) JO - Pediatr Rheumatol Online J VL - 15 UR - https://doi.org/10.1186/s12969-017-0154-4 DO - 10.1186/s12969-017-0154-4 ID - Abdul-Aziz2017 ER - TY - JOUR AU - Yao, L. AU - Yip, A. L. AU - Shrader, J. A. AU - Mesdaghinia, S. AU - Volochayev, R. AU - Jansen, A. V. PY - 2016 DA - 2016// TI - Magnetic resonance measurement of muscle T2, fat-corrected T2 and fat fraction in the assessment of idiopathic inflammatory myopathies JO - Rheumatology (Oxford) VL - 55 ID - Yao2016 ER - TY - JOUR AU - Day, J. AU - Patel, S. AU - Limaye, V. PY - 2017 DA - 2017// TI - The role of magnetic resonance imaging techniques in evaluation and management of the idiopathic inflammatory myopathies JO - Semin Arthritis Rheum VL - 46 UR - https://doi.org/10.1016/j.semarthrit.2016.11.001 DO - 10.1016/j.semarthrit.2016.11.001 ID - Day2017 ER -